{
    "2020-12-01": [
        [
            {
                "time": "2023-10-01",
                "original_text": "New Advances in Treating Difficult Blood Cancers From Johnson & Johnson and Others",
                "features": {
                    "keywords": [
                        "Advances",
                        "Blood Cancers",
                        "Johnson & Johnson"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "3 Pharma Stocks With Dividends Above 4% to Buy Now",
                "features": {
                    "keywords": [
                        "Pharma Stocks",
                        "Dividends",
                        "Buy Now"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "AbbVie to Host Virtual Immunology Strategic Update",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Immunology",
                        "Strategic Update"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}